235 related articles for article (PubMed ID: 8866596)
1. Comparison of inhaled salmeterol and individually dose-titrated slow-release theophylline in patients with reversible airway obstruction. European Study Group.
Paggiaro PL; Giannini D; Di Franco A; Testi R
Eur Respir J; 1996 Aug; 9(8):1689-95. PubMed ID: 8866596
[TBL] [Abstract][Full Text] [Related]
2. Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma.
Wiegand L; Mende CN; Zaidel G; Zwillich CW; Petrocella VJ; Yancey SW; Rickard KA
Chest; 1999 Jun; 115(6):1525-32. PubMed ID: 10378544
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, tolerability, and effects on quality of life of inhaled salmeterol and oral theophylline in patients with mild-to-moderate chronic obstructive pulmonary disease. SLMT02 Italian Study Group.
Di Lorenzo G; Morici G; Drago A; Pellitteri ME; Mansueto P; Melluso M; Norrito F; Squassante L; Fasolo A
Clin Ther; 1998; 20(6):1130-48. PubMed ID: 9916607
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and tolerability of inhaled salmeterol and individually dose-titrated, sustained-release theophylline in patients with reversible airways disease.
Fjellbirkeland L; Gulsvik A; Palmer JB
Respir Med; 1994 Sep; 88(8):599-607. PubMed ID: 7991885
[TBL] [Abstract][Full Text] [Related]
5. Salmeterol versus slow-release theophylline in patients with reversible obstructive pulmonary disease.
Taccola M; Bancalari L; Ghignoni G; Paggiaro PL
Monaldi Arch Chest Dis; 1999 Aug; 54(4):302-6. PubMed ID: 10546469
[TBL] [Abstract][Full Text] [Related]
6. Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. UK Study Group.
Boyd G
Eur Respir J; 1995 Sep; 8(9):1494-8. PubMed ID: 8575574
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment of asthmatic patients with salmeterol vs slow-release theophylline.
Nutini S; Martini T; Righi R
Respir Med; 1998 Apr; 92(4):683-90. PubMed ID: 9659537
[TBL] [Abstract][Full Text] [Related]
8. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
[TBL] [Abstract][Full Text] [Related]
9. Salmeterol versus theophylline in the treatment of asthma.
Pollard SJ; Spector SL; Yancey SW; Cox FM; Emmett A
Ann Allergy Asthma Immunol; 1997 May; 78(5):457-64. PubMed ID: 9164358
[TBL] [Abstract][Full Text] [Related]
10. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
Broseghini C; Testi R; Polese G; Tosatto R; Rossi A
Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852
[TBL] [Abstract][Full Text] [Related]
11. Comparison of salmeterol with beclomethasone in adult patients with mild persistent asthma who are already on low-dose inhaled steroids.
Vermetten FA; Boermans AJ; Luiten WD; Mulder PG; Vermue NA
J Asthma; 1999; 36(1):97-106. PubMed ID: 10077139
[TBL] [Abstract][Full Text] [Related]
12. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids.
Crompton GK; Ayres JG; Basran G; Schiraldi G; Brusasco V; Eivindson A; Jamieson AH; Olsson H
Am J Respir Crit Care Med; 1999 Mar; 159(3):824-8. PubMed ID: 10051257
[TBL] [Abstract][Full Text] [Related]
13. Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma.
Busse W; Nelson H; Wolfe J; Kalberg C; Yancey SW; Rickard KA
J Allergy Clin Immunol; 1999 Jun; 103(6):1075-80. PubMed ID: 10359889
[TBL] [Abstract][Full Text] [Related]
14. A 4-week comparison of salmeterol and terbutaline in adult asthma.
Hermansson BA; Jenkins RJ
Allergy; 1995 Jul; 50(7):551-8. PubMed ID: 8588686
[TBL] [Abstract][Full Text] [Related]
15. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group.
Lundback B; Rawlinson DW; Palmer JB
Thorax; 1993 Feb; 48(2):148-53. PubMed ID: 8493629
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of salmeterol compared to theophylline: meta-analysis of nine controlled studies.
Davies B; Brooks G; Devoy M
Respir Med; 1998 Feb; 92(2):256-63. PubMed ID: 9616522
[TBL] [Abstract][Full Text] [Related]
17. Effect of addition of inhaled salmeterol to the treatment of moderate-to-severe asthmatics uncontrolled on high-dose inhaled steroids. European Respiratory Study Group.
Faurschou P; Steffensen I; Jacques L
Eur Respir J; 1996 Sep; 9(9):1885-90. PubMed ID: 8880107
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
19. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
FitzGerald JM; Boulet LP; Follows RM
Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
[TBL] [Abstract][Full Text] [Related]
20. Formoterol 12 microg BID administered via single-dose dry powder inhaler in adults with asthma suboptimally controlled with salmeterol or on-demand salbutamol: a multicenter, randomized, open-label, parallel-group study.
Brambilla C; Le Gros V; Bourdeix I;
Clin Ther; 2003 Jul; 25(7):2022-36. PubMed ID: 12946548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
